FDA Import Refusal 112-2082549-6/1/2 — Glaxo Smith Kline

Glaxo Smith Kline — FEI 3004729711

The FDA refused shipment 112-2082549-6/1/2 from Glaxo Smith Kline (Brazil) on Dec 12, 2011. The refused product falls under Drugs and Biologics — CEFUROXIME AXETIL (CEPHALOSPORINS). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Dec 12, 2011
Country
Brazil
Product Category
Drugs and Biologics
Product Code
56CDA71 CEFUROXIME AXETIL (CEPHALOSPORINS)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.